LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-43.39% | 7.73 Mrd. | |
+11.68% | 3.7 Mrd. | |
+0.37% | 2.28 Mrd. | |
-21.21% | 1.99 Mrd. | |
-23.77% | 1.6 Mrd. | |
+18.25% | 739 Mio. | |
-10.04% | 687 Mio. | |
-36.12% | 461 Mio. | |
-4.47% | 279 Mio. |